Ceramide inhibits L-type calcium channel currents in GH3 cells

被引:18
作者
Chik, CL
Li, B
Karpinski, E
Ho, AK
机构
[1] Univ Alberta, Dept Med, Edmonton, AB T6G 2H7, Canada
[2] Univ Alberta, Fac Med, Dept Physiol, Edmonton, AB T6G 2H7, Canada
基金
加拿大健康研究院;
关键词
ceramide; Ca2+ channels; PKC; tyrosine kinase; GH(3) cells;
D O I
10.1016/j.mce.2003.10.048
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, we investigated the effect of ceramide on the L-type Ca2+ channel (L-channel) in GH(3) cells. We found that C6-ceramide, but not C6-dihydroceramide, the inactive analogue, had an inhibitory effect on BayK 8644-stimulated GH release. Using patch clamp analysis, C6- and C2-ceramide, but not C6-dihydroceramide, were found to inhibit the L-channel current. Increasing intracellular ceramide level with sphingomyelinase also inhibited the L-channel current. The inhibitory effect of ceramide on the L-channel current was attenuated by calphostin C, a myristolated pseudosubstrate protein kinase C (PKC) inhibitor, and lavendustin A, a tyrosine kinase inhibitor. Combined treatment with lavendustin A and the myristolated PKC inhibitor blocked the effect of ceramide on the L-channel current. These results indicate that ceramide, a lipid messenger of the sphingomyelin pathway, is an important regulator of the L-channel in GH3 cells and both tyrosine kinase and PKC are involved in this effect of ceramide. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 44 条
[1]   Structure-functional diversity of human L-type Ca2+ channel:: Perspectives for new pharmacological targets [J].
Abernethy, DR ;
Soldatov, NM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) :724-728
[2]   Cell-permeable ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and RhoA [J].
Abousalham, A ;
Liossis, C ;
OBrien, L ;
Brindley, DN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :1069-1075
[3]   MECHANISMS OF ACTION OF A 2ND GENERATION GROWTH HORMONE-RELEASING PEPTIDE (ALA-HIS-D-BETA-NAL-ALA-TRP-D-PHE-LYS-NH2) IN RAT ANTERIOR-PITUITARY-CELLS [J].
AKMAN, MS ;
GIRARD, M ;
OBRIEN, LF ;
HO, AK ;
CHIK, CL .
ENDOCRINOLOGY, 1993, 132 (03) :1286-1291
[4]   The versatility and universality of calcium signalling [J].
Berridge, MJ ;
Lipp, P ;
Bootman, MD .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) :11-21
[5]   Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms [J].
Bock, J ;
Szabó, I ;
Gamper, N ;
Adams, C ;
Gulbins, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (04) :890-897
[6]   Ceramide inhibits the outward potassium current in rat pinealocytes [J].
Chik, CL ;
Li, B ;
Karpinski, E ;
Ho, AK .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (02) :339-348
[7]   Ceramide inhibits L-type calcium channel currents in rat pinealocytes [J].
Chik, CL ;
Li, B ;
Negishi, T ;
Karpinski, E ;
Ho, AK .
ENDOCRINOLOGY, 1999, 140 (12) :5682-5690
[8]   MULTIPLE PATHWAYS ORIGINATE AT THE FAS/APO-1 (CD95) RECEPTOR - SEQUENTIAL INVOLVEMENT OF PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE-C AND ACIDIC SPHINGOMYELINASE IN THE PROPAGATION OF THE APOPTOTIC SIGNAL [J].
CIFONE, MG ;
RONCAIOLI, P ;
DEMARIA, R ;
CAMARDA, G ;
SANTONI, A ;
RUBERTI, G ;
TESTI, R .
EMBO JOURNAL, 1995, 14 (23) :5859-5868
[9]   Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? [J].
Cremesti, AE ;
Goni, FM ;
Kolesnick, R .
FEBS LETTERS, 2002, 531 (01) :47-53
[10]  
DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048